These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8701982)
1. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Higaki K; Yano H; Kojiro M Am J Pathol; 1996 Aug; 149(2):429-37. PubMed ID: 8701982 [TBL] [Abstract][Full Text] [Related]
2. Fas antigen expression in hepatocellular carcinoma tissues. Ito Y; Takeda T; Umeshita K; Sakon M; Wakasa K; Matsuura N; Monden M Oncol Rep; 1998; 5(1):41-4. PubMed ID: 9458289 [TBL] [Abstract][Full Text] [Related]
3. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]
4. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo? Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649 [TBL] [Abstract][Full Text] [Related]
5. Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy. Oka M; Hazama S; Suzuki M; Ogura Y; Kobayashi N; Suzuki T Hepatogastroenterology; 1995; 42(5):561-6. PubMed ID: 8751216 [TBL] [Abstract][Full Text] [Related]
6. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
7. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas. Shukuwa T; Katayama I; Koji T Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912 [TBL] [Abstract][Full Text] [Related]
8. Expression of functional CD40 in human hepatocellular carcinoma. Sugimoto K; Shiraki K; Ito T; Fujikawa K; Takase K; Tameda Y; Moriyama M; Nakano T Hepatology; 1999 Oct; 30(4):920-6. PubMed ID: 10498643 [TBL] [Abstract][Full Text] [Related]
9. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease. Bortolami M; Kotsafti A; Cardin R; Farinati F J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963 [TBL] [Abstract][Full Text] [Related]
12. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis. Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744 [TBL] [Abstract][Full Text] [Related]
13. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer. Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948 [TBL] [Abstract][Full Text] [Related]
14. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632 [TBL] [Abstract][Full Text] [Related]
15. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast. Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Wada Y; Nakashima O; Kutami R; Yamamoto O; Kojiro M Hepatology; 1998 Feb; 27(2):407-14. PubMed ID: 9462638 [TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 inhibited Fas-mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells. Chang YC; Xu YH Cell Res; 2000 Sep; 10(3):233-42. PubMed ID: 11032175 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883 [TBL] [Abstract][Full Text] [Related]
20. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells. You KR; Shin MN; Park RK; Lee SO; Kim DG Hepatology; 2001 Dec; 34(6):1119-27. PubMed ID: 11732001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]